All
How a Cemetery in an Abandoned Ghost Town Inspired One Patient With Cancer
August 24th 2021“I like to think the people of Bodie counted every day and made every day count, as hard as their lives were, reminding me to do the same,” writes a woman with metastatic breast cancer about her visit to Bodie State Historic Park.
FDA’s Welireg Approval A ‘Complete Game Changer’ for Certain Cancers Associated With VHL Disease
August 24th 2021The approval of Welireg, according to an expert at Massachusetts General Hospital, is “extremely important” and will “dramatically” change how certain von Hippel-Lindau-associated cancers are treated.
Investigational Cancer Treatment Being Evaluated in B-Cell Malignancies
August 23rd 2021Researchers are evaluating the safety and efficacy of zandelisib, an investigational cancer therapy, for the treatment of patients with marginal zone lymphoma and follicular lymphoma who have received at least two prior therapies.
A Caregiver's Wishes for a Woman With Metastatic Breast Cancer
August 23rd 2021A caregiver discusses her wishes for a woman who was recently diagnosed with metastatic breast cancer. “Most of all I wish that time will stand still for her, so that she can crawl into bed with her children and hold them as long as she wants to, feeling their bodies curl into hers as they sleep,” she writes.
Khloe's Story: the Tale of a Rare Pediatric Cancer
August 23rd 2021Khloe’s story is as unique as the rare neuroendocrine (NET) cancer she was diagnosed with in 2018. The medical team spanned three states including a NET specialist in pediatrics. Part 1 of this series introduces you to Khloe, her family and the beginning of a challenging journey.
Patient Recruitment Has Begun for Trial Assessing Cosela in Metastatic Bladder Cancer
August 20th 2021Preliminary results of the phase 2 trial assessing the safety and efficacy of Cosela with gemcitabine/platinum-based chemotherapy and Bavencio maintenance therapy for metastatic bladder cancer are expected to be released in the second half of 2022.
Keytruda-Lenvima Combo for Advanced Renal Cell Carcinoma Signifies ‘a Great Time for the Field’
August 20th 2021Frontline Keytruda plus Lenvima for advanced renal cell carcinoma is an effective treatment with life-prolonging benefits, although patients should be monitored for side effects that can be easily managed.
Third Dose of COVID-19 Vaccine May Increase Protection in Immunocompromised Patients
August 19th 2021Patients who are immunocompromised, such as patients with blood cancers, may get the boosted immunity needed to reduce their risk for contracting COVID-19 and hospitalization for compilations related to the virus.